DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Cenobamate
Cenobamate
Pharmacokinetic Drug–Drug Interactions Among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients
A Review of Carbamate Derivatives Used As Therapeutic Agents 285 Arh Hig Rada Toksikol 2020;71:285-299
Cenobamate
Risk Assessment and Risk Mitigation Review(S)
(STA) Cenobamate for Focal Onset
Schedules of Controlled Substances (.Pdf)
Clinically Relevant Drug-Drug Interaction Between Aeds and Medications Used in the Treatment of COVID-19 Patients
Cenobamate, a Sodium Channel Inhibitor and Positive Allosteric
Laws 2021, LB236, § 4
CP.PMN.231 Cenobamate (Xcopri)
A Report on Comparative Safety and Efficacy of Cenobamate in the Treatment of Partial Onset Seizures
Is Cenobamate the Breakthrough We Have Been Wishing For?
Anticonvulsants
Stembook 2018.Pdf
Randomized Phase 2 Study of Adjunctive Cenobamate in Patients with Uncontrolled Focal Seizures
Ontozry, Cenobamate
SENATE BILL No. 298
Xcopri (Cenobamate)
Top View
Medicaid List of Covered Drugs (Formulary)
Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, Effective January 20, 2021)
Am1434 Am1434 Lb236 Lb236 Ajc - 05/12/2021 Ajc - 05/12/2021
Xcopri (Cenobamate) NOTICE
Clinical Pharmacology and Biopharmaceutics Review(S) Office of Clinical Pharmacology Integrated Review
Towards Better Delivery of Cannabidiol (CBD)
Scheduling Actions - Chronological Order
International Nonproprietary Names for Pharmaceutical Substances (INN)
Ontozry, INN-Cenobamate
(Short Form) XCOPRI® (Cenobamate Tablets) CV
List of Scheduling Actions, Controlled Substances And
Summary Review
Briviact (Brivaracetam), Diacomit (Stiripentol), Epidiolex
Medical Policy Periodically
Authorization List for Step Therapy Drugs
Long Form) XCOPRI® (Cenobamate Tablets
New Drug Evaluation Monograph Template
Cenobamate for Partial Focal Epilepsy – Adjunctive Therapy NIHRIO (HSRIC) ID: 11789 NICE ID: 9872
“New Aeds: Do They Solve DRE (Drug Resistant Epilepsy)?”
Notice of Rulemaking Hearing
Clinical Policy: Cenobamate (Xcopri)
Adjunctive Cenobamate for Focal‑Onset Seizures in Adults: a Systematic Review and Meta‑Analysis
Randomized Phase 2 Study of Adjunctive Cenobamate in Patients with Uncontrolled Focal Seizures
CHANGES to the HIGHMARK DRUG FORMULARIES Following Is the Update to the Highmark Drug Formularies and Pharmaceutical Management Procedures for March/April 2020
Corporate Overview
New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (Aeds)
Therapeutic Drug Class
Anticonvulsants/Mood Stabilizers Effective: July 1, 2021
Preferred Drug List (PDL)
Cenobamate (Xcopri) Reference Number: ERX.NPA.142 Effective Date: 03.01.20 Last Review Date: 02.21 Line of Business: Commercial, Medicaid Revision Log
National Institute for Clinical Excellence
APIC Toxupdate May 2021
Cenobamate for the Treatment of Focal Seizures
Effective 07-01-2021) the Florida Medicaid Preferred Drug List (PDL